Farm Comunitarios. 2014 Dec 30;6(4):5-13. doi: 10.5672/FC.2173-9218.(2014/Vol6).004.02

The pharmacist as guarantor of patient health in the dispensation of acetylsalicylic acid 500 mg

Alonso Núñez ML, Pérez Benajas A, Calle J, Eyaralar T.
Alonso ML, Pérez A, Calle J, Eyaralar T. The pharmacist as guarantor of patient health in the dispensation of acetylsalicylic acid 500 mg. Farm Comunitarios. 2014 Dec 30;6(4):5-13. doi: 10.5672/FC.2173-9218.(2014/Vol6).004.02
Abstract : 

Introduction: Pharmacists hold the responsibility for dispensing of medicines in Spain. When the medicine is an Over the Counter (OTC) one, the pharmacist ensures its good use and prevents the appearance of an ADR (adverse drug reaction). Aspirin® (500 mg of ASA) is one of the best known OTCs. This study analyses the pharmacist’s interventions when 500mg ASA OTCs are dispensed. 

Material and methods: 18 community pharmacies took part in this prospective observational study. All interventions made by the pharmacists when patients, who demanded 500 mg ASA OTCs, where in a risky situation for its use, were documented from June 2013 to June 2014. 

Results: Pharmacists had to intervene 182 times out of the 3.355 ones a patient demanded a 500 mg ASA OTC (5.4% of the times). 20% of interventions where related to the length of treatment, 24% to pathologies where ASA was contraindicated, other 24% to lab tests alteration and 26% to drug-drug interactions.

Discussion: Pharmacist intervention prevented an ADR for the patient 5.4% of the times a 500 mg ASA OTC was demanded at the pharmacy. This leads us to think carefully about the possibility of taking ASA out of the pharmacy. This fact is supported by the lower number of ADR notifications in Spain compared to other European countries. 

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Related contents

Manual for authors

Journal Information